tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Buy Rating on ACADIA Pharmaceuticals Driven by Daybue’s Sales Growth and Market Expansion
PremiumRatingsBuy Rating on ACADIA Pharmaceuticals Driven by Daybue’s Sales Growth and Market Expansion
25d ago
Acadia Pharmaceuticals price target raised to $27 from $23 at BofA
Premium
The Fly
Acadia Pharmaceuticals price target raised to $27 from $23 at BofA
25d ago
Acadia Pharmaceuticals price target raised to $38 from $37 at Citizens JMP
Premium
The Fly
Acadia Pharmaceuticals price target raised to $38 from $37 at Citizens JMP
25d ago
Acadia Pharmaceuticals narrows FY25 revenue view to $1.045B-$1.095B
PremiumThe FlyAcadia Pharmaceuticals narrows FY25 revenue view to $1.045B-$1.095B
26d ago
Acadia Pharmaceuticals reports Q2 EPS 16c, consensus 14c
Premium
The Fly
Acadia Pharmaceuticals reports Q2 EPS 16c, consensus 14c
26d ago
ACAD Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ACAD Earnings this Week: How Will it Perform?
28d ago
ACADIA Pharmaceuticals: Hold Rating Amid Strategic R&D Focus and Competitive Challenges
PremiumRatingsACADIA Pharmaceuticals: Hold Rating Amid Strategic R&D Focus and Competitive Challenges
2M ago
Acadia Pharmaceuticals price target raised to $38 from $26 at RBC Capital
Premium
The Fly
Acadia Pharmaceuticals price target raised to $38 from $26 at RBC Capital
2M ago
Acadia court ruling supports Nuplazid exclusivity into 2030, says Mizuho
Premium
The Fly
Acadia court ruling supports Nuplazid exclusivity into 2030, says Mizuho
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100